Big Pharma’s Year of Big Spending Attempting to Evade Responsibility for High Prices and Advertise High-Priced Brand Name Products With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes […]
Take a Look Back on Big Pharma’s Year of Price Hikes And Skyrocketing Launch Prices With each new year comes a time-honored tradition for Big Pharma: Hiking prices on hundreds of brand name prescription drugs in the first two weeks of January. As Big Pharma’s next round of January price hikes approach, we can take […]
Senate Testimony Underscores Staggering Potential Cost of High-Priced Weight Loss Products for Consumers and U.S. Health Care System During a hearing last Thursday in the U.S. Senate Committee on Health, Education, Labor & Pensions (HELP) titled, “What is Fueling the Diabetes Epidemic?,” expert witness Kasia Lipska, M.D., M.H.S, Associate Professor of Medicine at the Yale […]
Big Pharma Eyeing Egregious Price Tags, Aggressive Marketing to Push GLP-1s for Weight Loss, After Decades of Shadow-Pricing to Drive-Up Insulin Prices WEIGHT LOSS DRUGS: A NEW FRONTIER FOR BIG PHARMA’S SAME OLD PRICING PRACTICES As 2023 comes to a close, one of the biggest stories in the drug pricing space this year has been […]
Big Pharma Continues Pushing Myth That Solutions to Lower Rx Prices Will Hamper Innovation, While Trumpeting Robust and Growing Innovation Pipelines to Investors Big Pharma is having trouble keeping its story straight. While the pharmaceutical industry continues to falsely argue that legislation designed to lower prescription drug prices by holding them accountable will undermine innovation, […]
New Analysis Showcases How Big Pharma Raises Prices on Blockbuster Products With No Increase in Clinical Value for Patients A new analysis from the Institute of Clinical and Economical Review (ICER) finds that brand name drug makers’ unjustified price hikes on just eight prescription medications cost the U.S. an additional $1.2 billion in 2022. ICER’s most recent Unsupported […]
Greater List Price Transparency Will Help Deter Big Pharma’s Egregious Pricing Practices and Arm Patients and Providers With Critical Information A recent Forbes column criticizing the Drug-Price Transparency for Consumers Act (DTC Act) misses the key value of this bipartisan solution and the relationship between Big Pharma’s price-gouging and the industry’s blockbuster spending on direct-to-consumer […]
KFF Survey Finds Americans Want White House Contenders Talking Rx Prices, After Separate Poll Finds Voters Overwhelmingly Back Solutions to Hold Big Pharma Accountable In case you missed it, the Kaiser Family Foundation (KFF) released a new tracking poll revealing that Americans are concerned with the affordability of health care, and want to hear candidates […]
Analysis Finds Bogus and Faulty Patents Contribute to Rising Prescription Drug Launch Prices According to coverage in STAT News, a recent analysis published in the Journal of the American Medical Association (JAMA) found U.S. Food and Drug Administration (FDA) approved patents secured by Big Pharma are more frequently invalidated than any other industry sector due to […]
Another Blockbuster Quarter for Profits as Big Pharma Maintains Business-as-Usual Approach to Price Gouging Americans Eli Lilly, GlaxoSmithKline and AstraZeneca rounded out earnings calls for Big Pharma for the third quarter. All three Big Pharma firms reported earnings that topped Wall Street expectations after participating in price hikes earlier this year. Eli Lilly Eli Lilly […]